IDEXX Labs (IDXX) Tops Q2 EPS by 12c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Northcoast Research Upgrades IDEXX Laboratories (IDXX) to Neutral
August 3, 2016 9:32 AM EDTNorthcoast Research upgraded IDEXX Laboratories (NASDAQ: IDXX) from Sell to Neutral.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $105.88 yesterday.
... MoreIDEXX Laboratories (IDXX) PT Raised to $120 at Stifel on 'Very Impressive' Q2
August 2, 2016 1:26 PM EDTStifel Buy analyst Jonathan Block reiterated a Buy rating and raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $120.00 (from $92.00) following "very impressive" 2Q16 results with revenue of $467MM and EPS of $0.74, well above our $447MM and $0.61 estimates.
Block commented, "Management raised 2016... More
